Triaging records and evidence after a potentially significant FDA inspection observation emerges
Determining whether the cited example indicates an isolated deficiency or broader quality-system exposure
Managing explanations and factual responses while investigation and evidence gathering are still underway
Distinguishing immediate containment and correction from root-cause investigation, CAPA, and systemic remediation
Deciding what can reasonably be corrected during the inspection and what requires documented follow-up
Structuring a Form FDA 483 response around findings, actions, evidence, responsibilities, and completion status
Establishing realistic remediation milestones without making premature or unsupported commitments
Managing follow-up evidence and demonstrating completion of promised corrective actions